Vidox Consulting will provide CUSTOMER with:

  • Local Knowledge: Up to date and detailed knowledge of the regulatory environment (Ethics Committee and Regulatory Authority procedures and requirements) in Region.
  • Physicians Network: In addition to its immediate infrastructure Vidox uses local Scientific Bodies as an extended base covering resources from basic scientific laboratories, to thousand bed clinical research hospitals and centres.
  • Access to Patients Patient referral network, recruitment strategy. We assist our customers in recruiting patients to participate in clinical trials through investigator relationships, media advertising, use of web-based techniques and other methods.
  • Access to Consumers Potential consumers of health products are patients and healthy visitors of our Investigators and clinical sites. Thousands of them may be targeted just in CEE capitals.
  • Project Resource: Availability of a highly trained and motivated team of medics, experts and industry professionals with previous experience in the area.
  • Web based technology: Extended user-proven internet technology allows targeting healthcare professionals and their patients around a Region.

The project team is confident in its ability to provide CUSTOMER with the best possible support in running the study in Russia through an experienced team.

We provide a full range of consulting services focused on helping our customers achieve regulatory success, from strategic planning and preclinical services to regulatory submission and approval.

VIDOX team have:

  • market expertise;
  • medical & scientific training;
  • local knowledge;
  • depth of service;
  • Eastern European capability.

Understanding of Local Culture

Patients in Eastern Europe sign PIC easier for different reasons:

  • Because they trust to the doctor (relationship between the investigator and the patient is in Russia and Ukraine and generally in CEE less formal and more personal than in WE). Doctors in CEE spend more time talking to patients than in WE.
  • Because they know that international Pharma offers eventually new possibilities for they disease which they otherwise eventually would not have
  • Because they do not need to buy the medication and pay for examinations
  • Because they get best possible medical care and best possible medical centers in their country